22 completed, 1 terminated, 1 unknown. 24 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 24 | Completed 22, Terminated 1, Unknown 1 |
Follow insulin glulisine: new trials by email Literature Review of insulin glulisine trials Research Report on insulin glulisine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Insulin Glulisine (GP40321) Compared to Insulin Glulisine (Apidra® SoloStar®) in Type 1 Diabetes Mellitus Patients GP40321, Apidra® SoloStar®, RinGlar® - Type 1 Diabetes Mellitis | Phase 3 | Completed | Geropharm | 224 | 2023-04-14 | 2025-07-22 |
| Afrezza® INHALE-1 Study in Pediatrics Afrezza, Rapid-acting Insulin Analog, Basal Insulin - Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 | Phase 3 | Completed | Mannkind Corporation | 319 | 2021-09-29 | 2025-05-06 |
| Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes (LixiLan-India) INSULIN GLARGINE/LIXISENATIDE (HOE901/AVE0010), INSULIN GLARGINE (HOE901), Metformin - Type 2 Diabetes Mellitus | Phase 3 | Completed | Sanofi | 247 | 2018-06-19 | 2022-04-25 |
| Safety and Efficiency of Linagliptin (Trajenta) in the Setting of Internal Medicine Department Linagliptin and Basal Insulin, Basal Insulin and Bolus Insulin - DM2 | Phase 3 | Unknown | Rabin Medical Center | 60 | 2017-10-01 | 2017-09-11 |
| Dapagliflozin As Additional Treatment To Liraglutide And Insulin In Patients With Type 1 Diabetes Dapagliflozin, Insulin, Liraglutide - Type 1 Diabetes Mellitus | Phase 3 | Completed | University at Buffalo | 26 | 2015-08-01 | 2024-01-24 |
| Efficacy and Safety of a Glargine-based Hospital Discharge Algorithm in Coronary Artery Bypass Graft (CABG) Patients Metformin, Glargine insulin, Glulisine - Poor Glycemic Control | Phase 3 | Completed | Emory University | 175 | 2012-10-01 | 2018-09-24 |
| REsearching Coronary REduction by Appropriately Targeting Euglycemia (RECREATE Pilot Study) glulisine insulin, glargine insulin - Hyperglycemia, Cardiovascular Diseases | Phase 3 | Completed | Population Health Research Institute | 500 | 2008-04-01 | 2010-06-16 |
| Effect of Lantus and Apidra in Patients With Acute ST Elevation Myocardial Infarction Insulin Glargine (LANTUS), Insulin Glulisine (Apidra), Standard Therapy - AMI | Phase 3 | Terminated | Sanofi | 34 | 2008-04-01 | 2011-02-11 |
| Insulin Glulisine, Insulin Lispro and Insulin Glargine in Type 1 or 2 Diabetes Mellitus Insulin Glulisine, Lispro, Insulin Glargine - Diabetes Mellitus | Phase 3 | Completed | Sanofi | 485 | 2007-01-01 | 2009-09-15 |
| Effect of Insulin Glulisine vs Regular Human Insulin on Postprandial Endothelial Function in Type 2 Diabetes Insulin Glulisine, Insulin - Diabetes Mellitus | Phase 3 | Completed | IKFE Institute for Clinical Research and Development | 15 | 2006-12-01 | 2007-11-21 |
| ELEONOR STUDY: Insulin Glulisine in Type 2 Diabetes Mellitus. Insulin glulisine, Insulin glargine, Metformin - Diabetes Mellitus, Type 2 | Phase 3 | Completed | Sanofi | 352 | 2005-10-01 | 2009-12-07 |
| Efficacy Study on the Control of Blood Glucose Concentration in Type 1 Diabetic Patients insulin glulisine / insulin glargine, insulin glulisin / insulin detemir - Diabetes Mellitus, Type 1 | Phase 3 | Completed | Sanofi | 88 | 2005-10-01 | 2009-12-07 |
| Insulin Glargine Plus Insulin Glulisine Multiple Daily Injections (MDI) Versus Premix Insulin Treatment in Subjects With Diabetes Mellitus (Type 1 or Type 2) insulin glargine, insulin glulisine - Diabetes Mellitus | Phase 3 | Completed | Sanofi | 582 | 2005-08-01 | 2009-06-04 |
| Comparison of the Ability of Glulisine With Lispro to Control Type 1 Diabetes Mellitus in Children and Adolescents Insulin glulisine, insulin lispro, insulin glargine - Diabetes Mellitus, Insulin-Dependent | Phase 3 | Completed | Sanofi | 572 | 2005-04-01 | 2016-05-20 |
| Insulin Glulisine, Diabetes Mellitus Type 1 Insulin glulisine - Diabetes Mellitus, Type 1 | Phase 3 | Completed | Sanofi | 104 | 2005-01-01 | 2009-09-18 |
| Efficacy and Safety of Insulin Glulisine in Type 1 Diabetes Mellitus insulin glulisine - Diabetes Mellitus, Type 1 | Phase 3 | Completed | Sanofi | 250 | 2004-12-01 | 2009-08-26 |
| Opposing Step-by-step Insulin Reinforcement to Intensified Strategy Insulin Glargine, Insulin Glulisine, Metformin - Diabetes Mellitus, Type 2 | Phase 3 | Completed | Sanofi | 811 | 2004-12-01 | 2009-09-15 |
| Insulin Glulisine in Diabetes Mellitus, Type 2 Insulin Glulisine, Insulin Therapy, Insulin Glargine - Diabetes Mellitus, Type 2 | Phase 3 | Completed | Sanofi | 311 | 2004-11-01 | 2009-09-15 |
| Insulin Glulisine Administered Pre-meal Versus Post-meal in Adult Subjects With Type 2 Diabetes Mellitus Receiving Insulin Glargine as Basal Insulin insulin glulisine, insulin glargine - Diabetes Mellitus, Type 2 | Phase 3 | Completed | Sanofi | 345 | 2004-08-01 | 2011-01-11 |
| Variable Bolus Regimen 1-2-3 for Type 2 Diabetes Mellitus insulin glulisine - Diabetes Mellitus, Type 2 | Phase 3 | Completed | Sanofi | 347 | 2004-08-01 | 2011-01-11 |
Showing 20 of 24. Sign in to see all of them.
Diabetes Mellitus, Type 2 (11) · Diabetes Mellitus (7) · Diabetes Mellitus, Type 1 (7) · Insulin Resistance (2) · Cardiovascular Diseases (1) · Hyperglycemia (1) · Myocardial Infarction (1) · Respiratory Aspiration (1)
Sanofi (17) · Emory University (1) · Geropharm (1) · IKFE Institute for Clinical Research and Development (1) · Mannkind Corporation (1) · Population Health Research Institute (1) · Rabin Medical Center (1) · University at Buffalo (1)
United States (8) · Germany (5) · France (4) · Italy (3) · Netherlands (3) · Russia (3) · Argentina (2) · Belgium (2) · Canada (2) · India (2) · Japan (2) · Mexico (2) · Poland (2) · Spain (2) · Sweden (2)
Karen Barch, B.S. (3) · Guillermo E Umpierrez, MD (1) · Hertzel Gerstein, MD, MSc, FRCPC (1) · Jing Fu (1) · Kevin Kaiserman (1) · Lisa Jean-Louis (1) · Marina Atarshchikova, MD (1) · Nitesh D Kuhadiya, MD, MPH (1)
PMID 18364392, PMID 19614946, PMID 19614947, PMID 21324825, PMID 21810024, PMID 21812890, PMID 22013886, PMID 22851487, PMID 27490915, PMID 30349602, PMID 41366610